Rocket One (RKTO) Non Operating Interest Expenses (2018 - 2022)
Rocket One's (RKTO) quarterly Non Operating Interest Expenses came in at $212677.0 in Q1 2022, up 17.56% year-over-year from $180903.0 in Q1 2021, and up 18.54% quarter-over-quarter from $179421.0 in Q4 2021.
Analysis
Rocket One (RKTO) Non Operating Interest Expenses (2018 - 2022) Analysis & Trends
Rocket One has disclosed Non Operating Interest Expenses across 5 years of filings, most recently posting $212677.0 for Q1 2022.
- In Q1 2022, Non Operating Interest Expenses rose 17.56% year-over-year to $212677.0; the TTM figure through Mar 2022 stood at $816982.0 (up 50.92% YoY), while the FY2021 annual figure was $785208.0, changed N/A from the prior year.
- Non Operating Interest Expenses came in at $212677.0 for Q1 2022 at Rocket One, up from $179421.0 in the prior quarter.
- In the past five years, Non Operating Interest Expenses ranged from a high of $218791.0 in Q2 2021 to a low of $41972.0 in Q3 2018.
- Average Non Operating Interest Expenses over 5 years is $134724.8, with a median of $135719.5 recorded in 2019.
- Year-over-year, Non Operating Interest Expenses jumped 309.02% in 2019 and tumbled 51.06% in 2020.
- Over 5 years, Non Operating Interest Expenses stood at $101951.0 in 2018, then rose by 19.86% to $122197.0 in 2019, then fell by 0.11% to $122063.0 in 2020, then jumped by 46.99% to $179421.0 in 2021, then advanced by 18.54% to $212677.0 in 2022.
- Per Business Quant data, the three most recent Non Operating Interest Expenses figures were $212677.0 in Q1 2022, $179421.0 in Q4 2021, and $206093.0 in Q3 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.04 Bn | 198.05 Bn | 7.24 Bn | 673.00 Mn |
| 2 | Gilead Sciences | 181.35 Bn | 178.17 Bn | 6.22 Bn | 247.00 Mn |
| 3 | Vertex Pharmaceuticals | 132.22 Bn | 124.37 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.94 Bn | 74.94 Bn | 3.93 Bn | 11.00 Mn |
| 5 | Argenx Se | 61.53 Bn | 56.34 Bn | 1.37 Bn | -1.00 Mn |
| 6 | Moderna | 54.25 Bn | 49.11 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.41 Bn | 31.10 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Biogen | 31.19 Bn | 29.91 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.10 Bn | 30.10 Bn | 1.16 Mn | - |
| 10 | Rocket One | 13.87 Mn | 5.98 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | 212,677.00 |
| Dec 31, 2021 | 179,421.00 |
| Sep 30, 2021 | 206,093.00 |
| Jun 30, 2021 | 218,791.00 |
| Mar 31, 2021 | 180,903.00 |
| Sep 30, 2020 | 122,063.00 |
| Jun 30, 2020 | 89,119.00 |
| Mar 31, 2020 | 149,242.00 |
| Dec 31, 2019 | 122,197.00 |
| Sep 30, 2019 | 171,675.00 |
| Jun 30, 2019 | 182,083.00 |
| Mar 31, 2019 | 62,622.00 |
| Dec 31, 2018 | 101,951.00 |
| Sep 30, 2018 | 41,972.00 |
| Jun 30, 2018 | 68,073.00 |
| Mar 31, 2018 | 46,714.00 |